For example, PTEN (an important negative regulator of the PI3K pathway) in melanoma is frequently mutated/deleted and its loss of function is present and concomitant with BRAF mutations in approximately 44% of melanomas [28,29]. The gene discussed is BRAF; the disease is melanoma.